Basic Materials / Specialty ChemicalsNasdaqCM
$1.79
+0.05 (+2.87%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 21%
FCF escenarios
weak_data · normalized FCF $-22.0M · quality 39.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
34/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$255M
P/E
179.0x
↑EV/EBITDA
11.5x
↑ROE
0.7%
↑Gross Margin
37.3%
↑Debt/Equity
0.52
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2019–2025 · 6 años de histórico normalizado
Revenue CAGR
+9.2%
FCF CAGR
—
FCF margin
-48.9%
FCF / Net income
-49.32x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $176.4M · net income $1.7M · FCF $-86.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | $176.4M | $176.4M | $175.7M | $174.9M | $205.6M | $148.1M | $100.2M | $104.0M |
| Net Income | $1.7M | $1.7M | $9.7M | $14.9M | $35.2M | $-4.5M | $4.6M | $5.8M |
| EBITDA | $32.3M | $32.3M | $41.0M | $45.3M | $65.7M | $26.2M | $25.7M | $30.8M |
| EPS | — | — | 0.07 | 0.11 | 0.25 | -0.03 | — | — |
| Gross Margin | 37.3% | 37.3% | 44.1% | 45.9% | 50.7% | 17.2% | 25.0% | 29.6% |
| Operating Margin | 2.3% | 2.3% | 10.1% | 14.1% | 24.0% | 2.3% | 3.6% | 10.6% |
| Net Margin | 1.0% | 1.0% | 5.5% | 8.5% | 17.1% | -3.1% | 4.6% | 5.6% |
| Balance Sheet | ||||||||
| Debt/Equity | 0.52 | 0.52 | 0.24 | 0.27 | 0.34 | 0.39 | 0.35 | — |
| Current Ratio | 0.85 | 0.85 | — | — | — | — | — | — |
| Cash Flow | ||||||||
| Free Cash Flow | $-86.2M | $-86.2M | $-18.5M | $-22.0M | $58.8M | $32.9M | — | — |
| Returns | ||||||||
| ROE | 0.7% | 0.7% | 3.8% | 6.0% | 15.5% | -2.5% | 2.9% | 3.8% |
| Valuation | ||||||||
| P/E | 179.00 | 179.00 | 70.57 | 75.45 | 43.00 | — | — | — |
| EV/EBITDA | 11.47 | 11.47 | 17.59 | 25.93 | 22.88 | — | — | — |
| P/B | 0.97 | 0.97 | 2.73 | 4.71 | 6.75 | — | — | — |
| Growth & Yield | ||||||||
| Revenue Growth | 0.4% | 0.4% | 0.5% | -14.9% | — | 47.8% | -3.6% | — |
| EPS Growth | — | — | -36.4% | -56.0% | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-2.7%
Start / end P/E
n/dx → n/dx
EPS bridge
0.07 → n/d
Residual
-2.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.